Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
British Journal of Haematology|November 1, 1996
A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studiesJ E Curtis, S Minkin, M D Minden, et al.Hematopathology and Molecular Hematology|January 1, 1996
Response of the blast stem cells of acute myeloblastic leukemia to G-CSF, GM-CSF, or the ligand for C-KIT, alone or in combinationE A McCulloch, S Minkin, J E Curtis, et al.Leukemia|March 1, 1991
Effects of rGM-CSF and rG-CSF on the cisplatin sensitivity of the blast cells of acute myeloblastic leukemiaY F Wang, C A Kelleher, S Minkin, et al.The Canadian Journal of Cardiology|April 19, 2007
Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in CanadaKiran K Kundhal, Siu Lim Chin, Lisa Harrison, et al.Blood|April 1, 1989
Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in cultureJ Miyauchi, C A Kelleher, C Wang, et al.Blood|January 15, 1994
Expression of the Kit and KitA receptor isoforms in human acute myelogenous leukemiaX Piao, J E Curtis, S Minkin, et al.Journal of Cellular Physiology|July 1, 1991
Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinosideG S Yang, C Wang, S Minkin, et al.British Journal of Cancer|September 2, 2005
A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammationW R Bruce, M Cirocco, A Giacca, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
High-dose cytosine arabinoside in the treatment of acute myelogenous leukemia: contributions to outcome of clinical and laboratory attributesJ E Curtis, H A Messner, M D Minden, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 19, 2003
The detection of change in mammographic densityJ Stone, A Gunasekara, L J Martin, et al.Pageof 6